ZyVersa Therapeutics Overview

ZyVersa Therapeutics Other Income Expense Net

Other Income/Expense Net for ZVSA.

Quarterly Other Income/Expense

-$488683.00

↑ 99.57% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

$3.32B

↑ 1460.18% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin